Katherine Dailey
FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say
Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked with rooting out dangerous manufacturing practices.
by Victoria Malis, Katherine Dailey and Sadie Leite, Medill Investigative Lab, and Debbie Cenziper and Megan Rose, ProPublica,
ProPublica Sued the FDA for Withholding Records About the Safety of Generic Drugs
The agency declined to quickly release documents that would identify drugs made at some of the most troubled foreign factories. The request was part of ProPublica’s ongoing investigation into the safety of America’s generic drug supply.
by Katherine Dailey and Jessie Nguyen, Medill Investigative Lab,